VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2011

Jun 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2011-06-01

Reporting Person: LEIDEN JEFFREY M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-01	Stock Option	$53.85	A	22500	Acquired	2021-05-31	Common Stock (22500)	Direct

Footnotes

F1: Fully vested.